Morgan Stanley Aflac - Search News

Market Is Not at Euphoric State Yet: Morgan Stanley's Slimmon

Andrew Slimmon, senior portfolio manager at Morgan Stanley Investment Management, sees "a balance of value and growth" amid the later stages of a classic bull market.

Business Insider · 9h

Morgan Stanley Keeps Their Buy Rating on Allstate (ALL)

Morgan Stanley analyst Bob Huang maintained a Buy rating on Allstate (ALL – Research Report) today and set a price target of $228.00. The

Seeking Alpha on MSN · 1d

Astera Labs dips after Morgan Stanley cuts rating on valuation

Morgan Stanley downgraded Astera Labs (NASDAQ:ALAB) to Equal-weight from Overweight due to full valuation and priced-in product ramps. The firm noted that Astera's stock is approaching its price target of $142.

Fintel on MSN · 1d

Morgan Stanley Upgrades Qorvo (QRVO)

Fintel reports that on January 21, 2025, Morgan Stanley upgraded their outlook for Qorvo (NasdaqGS:QRVO) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 7.52% Upside As of December 23,

Business Insider · 1d

Morgan Stanley Sticks to Its Sell Rating for Principal Financial (PFG)

In a report released today, Bob Huang from Morgan Stanley maintained a Sell rating on Principal Financial (PFG – Research Report), with a price

bovnews6d

How Does Aflac Inc (AFL) Stack Up Against Its Industry Peers?

On Wednesday, Aflac Inc (AFL) stock saw a modest uptick, ending the day at $104.79 which represents a slight increase of $1.14 or 1.10% from the prior close of $103.65. The stock opened at $ and ...

Morgan Stanley Sticks to Its Hold Rating for Willis Towers Watson (WTW)

Morgan Stanley analyst Bob Huang maintained a Hold rating on Willis Towers Watson (WTW – Research Report) today and set a price target of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now